The life sciences industry is undergoing rapid change, dynamic discoveries and pressures driving business decisions and corporate growth. Business models are being forced to evolve as healthcare continues to shift from a treatment focus to points of wellness, prediction, personalization, and prevention.
Recognizing the interdependence of the payer, provider and pharmaceutical value chains, companies are re-inventing strategies in multitude ways: increased outsourcing, co-development and patient engagement are the new norms.
The Frost & Sullivan Global Life Sciences Program helps you better understand stakeholder dynamics as the healthcare system transitions from acute care into integrated care. Our research and insights help you make informed strategic decisions around how best to navigate this complex market.
We can support needs from syndicated research to projects ranging from proprietary strategic engagements and market research, marketing solutions, and whitepapers, all leveraging the global reach of our firm to propel your business forward.
We believe a structured partnership that provides you transformational insights through online content as well as deeper interaction with our senior analyst team will help ensure greater relevancy of insights provided for your organization.
Meet the Team
Global Vice President
Frost & Sullivan's expertise in Life Sciences research and consulting includes work in the following strategic and operational areas.
Pharmaceuticals & Biotech
Competitive analysis series covering: oncology, diabetes/metabolic diseases, neurology, cardiovascular diseases and infectious diseases.
In Vitro Diagnostics & Research Tools
Market analysis series covering: molecular Dx (incl. companion Dx), POCT, clinical lab services, next generation sequencing and chromatography/research antibodies.
Market insights series covering: regenerative medicine, biosimilars, generics 2.0, CRAMS, digital pathology, downstream bioprocessing and antibody drug conjugates.
- Innovating business models that promise sustainable revenue streams
- Designing integrated data platforms that empower consumers
- Developing strategic partnerships that bring novel products and services to the market
- Establishing industry best practices
- Identifying emerging markets opportunities
Personalized medicine continues to be a driver of new diagnostics to characterize the properties of an individual s cancer. As a result, there is an increased focus on the development of non-invasive liquid biopsy companion diagnostic tests that would aid in choosing the best treatment for an…
The latest edition of the Drug Discovery TechVision Opportunity Engine (TOE) profiles emerging technology platforms for drug discovery and development. These platforms are diverse and span the spectrum of the life sciences industry, from tissue engineering to companion diagnostics, biomarkers, and…
This edition of the Genetic Technology TOE depicts the current landscape and the new trends across the life sciences industry. Biotechnology innovations in drug discovery, 3D printing, and skin testing are exhibited. The corresponding drug validation scenario is depicted, along with industry…
This edition of the Genetic Technology TOE depicts trends across cellular therapies. CAR-T Cell clinical trials and industry interactions are depicted. In particular, a clinical trial overview involving CAR T cells worldwide solid tumors is illustrated.
The Genetic Technology TechVision…
There is high growth in the Asia-Pacific (APAC) oncology diagnostics market due to increasing incidence of cancer and the drastic reduction in incidence age owing to a plethora of reasons in the regional market. The major drivers for the APAC cancer diagnostics market are increase in adoption of…
The Western European Oncology Diagnostics Market, Forecast to 2021 study presents an overview of the oncology diagnostics market landscape in the Western European countries, with a focus on EU 5. The analysis provides forecasts for the EU 5 markets, segmented by types of cancer, which include breast…
This edition of the Genetic Technology TOE depicts trends across peptide therapeutics. The study covers a variety of disease indications in which peptide therapeutics are being used. A summary of interventional, industry-funded clinical studies using peptide therapeutics for leukemia is also…
Preference to Targeted Therapies and Patient Centric Approaches Drive Transformations in Oncology Drug Delivery Market
Cancer is the second largest cause of death and is expected to surpass cardiovascular diseases as the leading cause of deaths over the next few years. According to NIH estimates, medical expenditure for cancer in the United States is expected to cross $150 billion by 2020, thereby putting even…
Microbiome science has become a key area of research for biopharmaceutical companies. At present, there are multiple start-ups emerging, which are focusing their resources towards the development of novel therapeutics as well as diagnostic/screening technologies and services. In an era of…
Blockchain technology, with its ubiquitous security infrastructure for seamless health data exchange, holds potential to eliminate the burden and cost of health data reconciliation and facilitate interoperability. Emerging blockchain systems promise to unlock new economic advantages by…
Frost & Sullivan's Growth Consulting services support our clients who require customized and collaborative solutions to help their companies meet revenue targets, capture market share and expand portfolios. Most projects are focused on addressing highly strategic challenges that require creative research techniques and deep market insights to address our clients’ specific needs. Our projects focus on ten primary areas:
Growth Consulting clients are primarily healthcare technology and service providers such as medical device and diagnostic companies, pharmaceutical and biotech manufacturers, and firms in the healthcare information technology and connected health markets. Companies supporting these firms, whether for professional services and logistics or components and software, also regularly turn to us for insight into the multi-billion dollar healthcare vertical. Our broad base of capabilities can be leveraged by any entity seeking to grow in the intersection between healthcare and technology innovation.
Recognizing each project as unique, Frost & Sullivan crafts the optimal approach to addressing our clients’ needs. These tools may include:
Why Partner with Frost & Sullivan?
- Deep subject matter expertise with highly educated consultants focusing entirely on the healthcare technology sector
- More than 45 locations around the world to provide unparalleled global access and insights
- Collaborative teams that formed across industry sectors supporting healthcare technology vertical, e.g. materials, mobility and wireless, power systems, sensors, software, logistics, transportation, food, and others
- Strong reputation and deep network of healthcare technology contacts to support rapid and insightful industry research and networking
- Decades of experience in epidemiological, financial, and competitive forecast modelling, providing quantitative rigor and to all our engagements
- Proven processes and methodologies tested across hundreds of projects with the world’s leading firms
- Creative thought leadership and deep insights into market dynamics to help product development teams and executives create and validate new whitespace opportunities
- Ability to design and facilitate on-site workshops with our clients which use proprietary exercises to evaluate opportunities, develop strategies and reach consensus on next steps
- An established brand known for excellence in the field of healthcare technology innovation that can be leveraged for custom whitepapers, e-broadcasts and other tactical marketing initiatives
- A highly-skilled team of quantitative research professionals capable of designing and executing complex methodologies, including conjoint analysis, MaxDiff, multivariate analysis and others
- Access to a broad network of affiliated service partners and third party data tools to extend our capabilities
|Types of Companies||Examples of Recent Projects|
|Healthcare Providers||Assessing Licensing Potential for an Enterprise Learning System of a Leading Tertiary Healthcare Provider|
|Suppliers/ Service Providers to Industry||Interactive Digital Whitepaper with Embedded Video on the Future of the Global Healthcare Products Supply Chain for a Major Logistics Company|
|Consumer Health||Competitive Profiles on 1,200+ Weight Loss and Skin Care Product Available Worldwide to Support R&D Efforts of a Major Competitor|
|Investors||Buy-Side Valuation Analysis and Financial Modeling for Investment Consideration in an Energy-Based Medical Device Start Up|
|Professional Associations||Annual Customer Survey on U.S. Purchasing Patterns for Laboratory Products Commissioned by a Leading Industry Association|
Frost & Sullivan’s Growth Workshops help clients establish a narrow portfolio of key market opportunities from a larger pool of options. These interactive sessions help clients identify the strongest opportunities in the market and brainstorm strategies for pursuing those opportunities. Growth Workshops run the gamut of market analysis, from opportunity identification to strategy development to planning and implementation. Each workshop’s design is based on the full breadth of client objectives and desired outcomes.
Growth Workshop Consultants help clients funnel and prioritize which opportunities fit best with the company's internal capabilities. During these workshops, attendees gain market knowledge and are trained on evaluation tools and techniques to translate market, competitive, technical, regulatory and economic implications into specific growth opportunities.
Frost & Sullivan’s Growth Workshops use a range of tools and exercises to help clients identify and prioritize key market opportunities, such as:
- Opportunity/Fit Matrix
- Decision Support Scorecard
- Strategy Mapping
- Executive Alignment Surveys
"Frost & Sullivan worked with Tissue and Eye Services (a division of NHS Blood and Transplant) to deliver an informed opinion on market potential and dynamics in the tissues market. Their thought leadership on market segmentation, market share and insights into what influenced customers buying behaviour enabled us to reassess our strategy and focus on products that would deliver growth. Their partnership approach worked for us and they were responsive to our challenge and questions in specific areas of interest."
"We have been very satisfied with the consulting project we commissioned with Frost & Sullivan. The analysts were responsive to our needs and accessible during the project. The finished research was quite thorough and, as we later saw, proved to be a highly accurate depiction of the market."
"We have found Frost & Sullivan’s work to be nothing short of excellent. The consulting project results were concise and cohesive, leading us to better understand a market that is usually complex and difficult to research."
"We have relied on Frost & Sullivan’s strategic research studies for reliable insights into several competitive markets. Their ability to identify and analyze industry-specific trends gives their clients not only a clear indication of where markets are going, but why they are going there."
"The team was knowledgeable and not only determined what information would be helpful in the long-term, but delivered it in a short amount of time. The study helped us make good strategic decisions, backed by reliable market-based information."
“It was great to talk to your analysts and grateful for everything you and the team do to support our company on a daily basis.”
Global Market Intelligence Manager, Medical Devices Company
"You are my most trusted source for information on a myriad of topics.”
Fortune 500 Company
"This looks very comprehensive and a huge piece of work. Definitively a vendor we can consider for some of our later stage assets."
Global Strategic Marketing, Oncology, Pharma Company